Abstract
Castleman's disease is a rare lymphoproliferative disorder that may affect the liver as part of mutlicentric disease or, rarely, as unicentric hepatic disease. Primary hepatic disease is difficult to diagnose but demonstrates diffusion restriction on magnetic resonance scan and can be treated curatively with hepatic resection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Soumerai J, Sohani A, Abramson J. Diagnosis and Management of Castleman Disease. Cancer Control. 2014; 21(4); 266–278
Amy Y Liu, Christopher S Nabel, Brian S Finkelman, Jason R Ruth, Razelle Kurzrock, Frits van Rhee, Vera P Krymskaya, Dermot Kelleher, Arthur H Rubenstein, David C Fajgenbaum. Idiopathic multicentric Castleman’s disease: a systematic literature review. The Lancet: Haematology. 2016; 3(4): e163–e175
White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM, Diffusion-weighted imaging in cancer: physical foundation and application of restriction spectrum imaging. Cancer Research 2014;74:4638–4652
Authors’ Contributions
All four listed authors contributed to the conception, analysis and drafting of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maundura, M., Hayward, G., McKee, C. et al. Primary Castleman’s Disease of the Liver. J Gastrointest Surg 21, 417–419 (2017). https://doi.org/10.1007/s11605-016-3227-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-016-3227-7